STOCK TITAN

PHARM-BIO SERV INC (PBSV) Revenue by Year

PBSV

PHARM-BIO SERV INC generated $9.0M in revenue in fiscal year 2025. This represents a decrease of 5.3% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $9.5M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters PHARM-BIO SERV INC has filed alongside them.

FY2025 annual
Revenue $9.0M
YoY -5.3%
5Y CAGR -16.0%
10Y CAGR -9.1%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jul 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PBSV Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$9.5M$9.0M-5.3%$9.5M-44.0%$17.0M-12.5%$19.4M-3.6%$20.1M-6.7%$21.6M+10.5%$19.5M+9.6%$17.8M+33.8%$13.3M-31.9%$19.5M-16.5%$23.4M-15.1%$27.6M-16.7%$33.1M+13.1%$29.2M+46.6%$19.9M

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

PBSV Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Revenue$2.3M+19.0%$2.7M+11.8%$2.3M-7.1%$2.1M-7.9%$2.0M-18.8%$2.4M+1.7%$2.5M+3.8%$2.3M-35.2%$2.4M-47.2%$2.4M-47.9%$2.4M-43.8%$3.6M-22.4%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More PHARM-BIO SERV INC financials

Frequently Asked Questions

What was PHARM-BIO SERV INC's revenue in fiscal year 2025?

PHARM-BIO SERV INC generated $9.0M in revenue in fiscal year 2025.

How fast is PHARM-BIO SERV INC's revenue growing?

PHARM-BIO SERV INC (PBSV) revenue fell by 5.3% year over year, from $9.5M to $9.0M in fiscal year 2025.

What is PHARM-BIO SERV INC's revenue over the last twelve months?

PHARM-BIO SERV INC (PBSV) reported $9.5M in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, PHARM-BIO SERV INC (PBSV) revenue went from $19.9M in fiscal year 2011 to $9.0M in fiscal year 2025.

PHARM-BIO SERV INC (PBSV) reported $2.3M in revenue in Q3 2026. This represents an increase of 19.0% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what PHARM-BIO SERV INC (PBSV) reported on that line in every period on record.